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ABSTRACT 
Aptamers are short oligonucleotide sequences that are capable of binding with high affinity and 
specificity to a wide variety of targets. The selection of aptamers from a random oligonucleotide 
library, by cell-SELEX, has lead to their in vivo application in both research and clinical settings. 
Cell-SELEX continues to be hindered by the non-specific binding of selection sequences to the 
complex cell surface as well as low specificity in the PCR amplification of DNA. In this work 
the cell-SELEX procedure was optimized to improve the efficiency of aptamer selection using 
three modifications: masking DNA characterization, non-SELEX selection and touchdown PCR. 
An established masking DNA model was tested against the MCF-7 and 4Tl cell lines and was 
shown to be capable of determining the masking DNA concentration needed for aptamer 
selection. The traditional SELEX approach was combined with a non-SELEX aptamer selection 
protocol to reduce the concentration and heterogeneity of sequences collected after the first 
round of selection thus leading to more accurate PCR amplification and a decrease in byproduct 
formation. Lastly, touchdown PCR was used to successfully eliminate the amplification of 
genomic DNA reducing the formation of genomic DNA byproducts. 
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Chapter 1: APTAMER SELECTION AND APPLICATION 
1.1 Evolution of Aptamer Development 
1.1.1 Discovery of Aptamers and the SELEX Procedure 
Aptamers are oligonucleotide sequences typically up to 100 nucleotides in length, which 
can be selected to bind with high affinity and specificity to a wide range of targets [ 1]. Two 
separate groups simultaneously introduced the concept of aptamers, and process through which 
they are selected. Ellington and Szostak were the first to coin the term aptamer, which was based 
on the Greek word "aptus" meaning to fit. In their work they were able to successfully select a 
variety of RNA sequences that were able to bind with high affinity and varying levels of 
specificity to a variety of organic dyes immobilized on a chromatography column [ 1]. 
The process began with the synthesis of a ssDNA library which was transcribed into 
RNA. Each RNA sequence consisted of a random region approximately 100 nucleotides in 
length, flanked by constant primer regions to allow for polymerase chain reaction (PCR) 
amplification and transcription of target bound sequences. The targets of aptamer selection were 
various organic dyes, including Cibarcron Blue 3G 1, Reactive Red 120, Reactive Yellow 86, 
Reactive Brown 10, Reactive Green 19 and Reactive Blue 4. Chromatography columns were 
prepared by immobilizing agarose beads with covalently bound target dyes. The RNA library 
was then applied to each column to allow any potential aptamers to bind to the immobilized 
target dyes. The column was washed with a high salt concentration buffer to remove any 
unbound or loosely bound RNA sequences. Lastly, tightly bound sequences were eluted with 
water and transcribed into cDNA via reverse-transcription PCR (RT-PCR) to allow PCR 
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amplification by Taq polymerase. The resulting pool of DNA was then converted back into RNA 
and used for the subsequent round of selection. The affinity of the aptamers was tested by 
measuring the percentage of RNA bound to the immobilized target column versus the percentage 
that eluted. With every round of selection the amount of RNA that adhered to the target 
increased, maxing out at approximately 80% of sequences bound. Once a significant increase in 
affinity was evident, the pool of RNA was cloned and sequenced to identify aptamers. The initial 
library consisted of a total of 1015 unique RNA sequences. Following four rounds of selection 
approximately 10 sequences, some unique and some with common elements, that could bind 
with high affinity and variable specificity to the range of organic dyes [7]. 
Gold and Tuerk performed a similar selection process, against the target T4 DNA 
polymerase. Gold and Tuerk were the first to name the process of aptamer selection as systemic 
evolution ofligands by exponential enrichment or SELEX [8]. Gold and Tuerk wanted to 
identify RNA sequences that were capable of binding to the ribosome binding site of the 
bacteriophage T4 DNA polymerase, which is typically bound to a 5 base pair helix with a unique 
8 nucleotide loop. Instead of having a large variable region, their library consisted of a mere 8 
nucleotide variable loop with the remainder of the sequence being made up of a fixed 5 base-pair 
helix and the constant primer regions to allow for reverse transcription and amplification of 
bound sequences. Starting with just over 65 000 different sequences, Tuerk and Gold were able 
to identify two high affinity sequences that could bind to the T4 DNA polymerase ribosome-
binding site, one of which was the wild type target and the other a previously unidentified 
aptamer [8]. 
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Figure 1.1 - An outline of the systemic evolution of ligands by exponential enrichment (SELEX) 
procedure used to identify aptamer against purified targets such as proteins. This figure was 
adapted from [3]. 
1.1.2 - The Overall SELEX Procedure 
The SELEX process begins with the generation of a ssDNA or RNA library consisting of 
a random region, flanked by distinct primer regions used for the transcription and amplification 
of bound sequences between rounds. With the current advancement of technologies libraries can 
now be purchased commercially at a relatively low cost, consisting of various length of primer 
and randomized regions. Both ssDNA and RNA libraries have been successfully used for 
aptamer selection [1]. In general, ssDNA libraries are cheaper to work with and do not require 
the reverse transcription prior to amplification. On the other hand, RNA libraries are available 
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with a wider modification variety, which can be introduced both during the PCR amplification 
step of the SELEX procedure and following the sequencing of selected aptamers [l]. 
A broad outline of the SELEX procedure is present in Figure 1.1 [3]. The process begins 
with the incubation of a randomly generated RNA or ssDNA library with the target of interest. 
The target of interest can be presented in a variety of ways including bound to agarose beads in 
suspension, purified protein in binding buffer, on a chromatography column or coated on a 
nitrocellulose filter [7, 8]. Sequences that bind tightly to the target are then separated from 
unbound and loosely bound sequences and are eluted from the target by thorough washing. The 
bound sequences are amplified via PCR and the resulting enriched pool is used for the 
subsequent round of selection [7, 8]. Since its initial introduction in the 1990s the SELEX 
process has evolved tremendously. 
To date, numerous methods separating bound and unbound sequences have been 
introduced improving the efficiency of selection [9, 1 O]. Depending on the target of interest, 
specifically its ability to bind to oligonucleotides and its complexity, the SELEX procedures can 
take anywhere from 4 to 20 rounds of selection to reach a sufficiently high affinity aptamer pool 
[11]. In most cases, the final aptamer pool is then cloned and sequenced to identify the specific 
ssDNA or RNA sequences that bind with the highest affinity and specificity to the target of 
interest [7, 8]. Once specific sequences are obtained, their affinity for the target is determined by 
calculating the dissociation constant (Kd) which typically ranges in the low nM to pM range for 
strong binding aptamers [ 11]. 
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Figure 1.2 - Non-SELEX approach to aptamer selection against a purified product. The non-
SELEX method consists of consecutive incubation and partitioning steps without PCR 
amplification of sequences in between [ 4] 
1.1.3 Non-SELEX Selection of Aptamers 
Previous work in our lab has shown that aptamer can also be selected using a modified 
non-SELEX approach [4]. In this approach the exponential enrichment of collected sequences is 
bypassed and consecutive incubations are performed (Figure 1.2). This provides the advantage 
of a faster aptamer selection protocol as well as a decreased consumption of reagents typically 
used at every round of PCR for sequence amplification and product clean-up. In addition this 
approach has the potential to be applied to libraries which are not easily amplifiable such as 
those composed of modified bases [ 4]. 
1.1.4 Evolution of SELEX targets 
SELEX can theoretically be applied to an endless variety of targets ranging from simple 
small molecules all the way to membrane fragments, whole cells and whole tissue samples. The 
first two SELEX procedures were performed against purified targets, specifically organic dyes 
[8] and the bacteriophage protein T4 DNA polymerase [8]. Since then, SELEX targets have 
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expanded tremendously. Selecting against a purified target, such as a protein or small molecule, 
usually required few rounds, but can present the challenge of a having limited number of 
potential binding sites [ 1]. On the other hand, when selecting for unpurified targets the increased 
complexity is accompanied by the necessity for an increased number of rounds [6]. 
The selection of aptamers against unpurified targets was first done by Morris et. al. in 
1997 against human red blood cell (RBC) ghosts [12]. RBC ghosts were created by lysing RBCs 
so that only the membrane remained, and all intracellular components were removed. Without 
having a specific epitope in mind Morris et. al. selected a heterogeneous pool of aptamers that 
were able to bind with high affinity and specificity to several proteins on the RBC membrane. 
Furthermore, by cross-linking the aptamers with their membrane targets the authors were able to 
confirm that individual sequences had unique targets [12]. 
Aptamers have been selected for a variety of viruses including human immunodeficiency 
virus (HIV) [13], human cytomegalovirus (HCMV) [14] and Rous sarcoma virus (RSV) [15]. 
Viruses were grown within a cell culture, collected and incubated with a starting SELEX library. 
Following anywhere up to 16 rounds of selection, aptamers were selected that, could not only 
bind to the target virus with high affinity and specificity, but that were also capable of reducing 
the virulence of viruses against the host cells [14, 15]. 
The first aptamer selected for a living target was performed against the protozoan 
pathogen African trypanosomes [ 16]. Previous attempts to select a functional antibody against 
the pathogen were unsuccessful since antibodies could only be selected against the quickly 
evolving main shell of the organism. On the other hand aptamers were successfully selected, 
following a mere ten rounds of SELEX, that were capable of binding the flagellar pocket of the 
6 
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Figure 1.3 - Outline of the cell-SELEX procedure consisting of a counter selection using 
negative cells and a positive selection using target cells. This figure was adapted from [2]. 
organism that does not undergo mutations and is an ideal target for therapeutics. This 
demonstrated the fact that aptamers are so much smaller in size (lOkDa) compared to antibodies 
( 180kDa) allows them to bind to areas which are inaccessible to anti body selection [ 16]. 
Aptamer selection against eukaryotic cells was first performed by Blank et. al. in 2001 
against mouse YPEN-1 endothelial cells. Due to the complexity of the eukaryotic cell surface 28 
rounds of SELEX selection were necessary. The resulting aptamer was successfully used to 
differentiate between micro-vessels ofrat glioblastoma and those of healthy rat brain [17]. Since 
then aptamers have been selected against a wide variety of cell lines, most commonly against 
cancer cells [1], through a modified procedure commonly referred to as cell-SELEX [6]. Most 
recently, segments of cancer tissue, embedded in paraffin, were used as a selection target 
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resulting in a heterogeneous pool of aptamers that could recognize biomarkers on the cell surface 
as well as within the extracellular matrix [17]. 
1.2 Cell-SELEX 
1.2.1 Cell-SELEX procedure 
Cell-SELEX is very similar to the original SELEX procedure with some additional steps to 
compensate for the increased complexity of the target. The diagram depicting the cell-SELEX 
procedure is presented in Figure 1.3 [2]. Typically cell-SELEX consists of two different sets of 
selection: a positive selection against target cells and a negative or counter selection against non-
target cells. Traditionally, positive selection is performed against a pathological tissue while the 
negative selection is performed using the healthy counterpart [6]. Positive selection commonly 
occurs against tumor cells resulting in aptamers that are capable of distinguishing between 
cancerous and non-cancerous tissue. However, other combinations have been used to select more 
specific aptamers such as those that distinguish between mature and immature dendritic cells 
[18]. 
Cell SELEX begins in a similar fashion to traditional SELEX with the incubation of 
target cells with a ssDNA or RNA library typically consisting of approximately 1015 unique 
sequences [ 6]. Selection conditions vary depending on the intended future application of the 
. 
aptamer. The majority of aptamers selected via cell-SELEX are intended for in vivo applications, 
thus they should be selected for in physiological conditions (3 7°C and pH of 7-8). Previous work 
has shown that aptamers selected under non-physiological conditions have a decreased affinity at 
physiological conditions making them non-functional [19]. 
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Following incubation, under the proper conditions, weakly bound and unbound sequences 
are separated from target bound sequences, commonly through centrifugation and multiple 
washes. The bound sequences are then eluted from the target cell by heat dissociation and 
amplified via PCR. If an RNA pool is used for selection, sequences are first converted to 
complementary DNA (cDNA) through reverse transcription PCR (RT-PCR) and then amplified 
by traditional PCR methods [6]. 
Subsequent rounds are preceded or followed by a round of negative selection. The 
cleaned-up PCR product from the previous round is incubated with the negative cells in identical 
conditions as with the positive selection incubation. In the negative round it is the unbound 
sequences that are collected and used for the subsequent round of positive selection. Negative. 
selection reduces the amount of non-specific sequences collected during positive selection and 
ensures that the aptamers that are selected are unique to the pathogenic target and not to 
ubiquitous cellular epitopes [ 6]. 
The progress of selection during cell-SELEX is typically monitored via flow cytometry. 
DNA from each round is amplified using a fluorophore labeled primer such as fluorescein. The 
amplified pool of labeled sequences from each round is incubated with the target cell line. 
Unbound sequences are rinsed off, cells are re-suspended in binding buffer and analyzed via 
flow cytometry. Any sequences bound to the target cells will emit a fluorescent signal due to the 
addition of the fluorescent probe. This fluorescent signal is picked up by the flow cytometer and 
a histogram representing the number of events (i.e. cells) versus the relative fluorescence (given 
as relative fluorescence units or RFUs) emitted at a specific wavelength, is constructed. As 
selection progresses the number of events that result in a higher RFU signal will increase moving 
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the overall histogram right along the x-axis as shown in Figure 1.4A. This overall increase in the 
RFU signal indicates an increased number of sequences bound to target cell implying an increase 
in aptamer pool affinity to the target. At the same time, incubation of the selection pools with the 
negative or counter selection cell line should not show any increase in fluorescence intensity 
(Figure 1.4B). Selection typically continues until no significant increase is seen in RFUs from 
one round to the next [ 6]. 
1.2.2 Non-specific binding of sequences 
The cellular surface is very complex, consisting of thousands of potential selection targets 
including proteins, glycoproteins and phospholipids [20]. While this means that numerous 
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Figure 1.4 Flow cytometry histogram used to monitor the progress of aptamer selection. Both 
target (A) and negative cells (B) are incubated with sequence pools from several roum.ds and 
analyzed by flow cytometry creating a histogram of the number of events versus fluorescence 
signal. An improvement in the affinity is evident by the shift of the histogram peak right along 
the x-axis indicating an increase in the mean fluorescence of the cell sample analyzed. This 
figure was adapted from [ 6]. 
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aptamers can be selected against a single cell type, it also creates the additional pr©blem of a 
large amount of non-specific binding of oligonucleotides to the cell surface. This large amount of 
non-specifically bound sequences translates to an increase in the number of selection rounds 
necessary to obtain a high affinity aptamer pool. In addition, the collection of non-specific 
sequences along with potential aptamers means that the sequences will compete for PCR 
reagents resulting in a decreased number of high affinity sequences being amplified [ 6]. 
Non-specific sequences are also collected during selection due to dead cells taking up 
nucleic acids from the cell-SELEX suspension. Several studies have shown that dead cells 
become increasingly permeable to both RNA and ssDNA sequences and take up a large amount 
of sequences non-specifically [21]. In fact, the number of sequences collected from dead cells is 
exceedingly greater than the number of sequences that typically adhere to a living cell's 
membrane [10]. These sequences are then amplified along with the high affinity binders resulting 
in a decreased efficiency in the selection of high-affinity aptamers. Furthermore, the non-specific 
uptake of sequences by dead cells during negative selection may result in a loss of potential 
aptamers from the selection pool. If negative selection cells take up potential aptamer sequences 
non-specifically, these sequences will not be available for the subsequent round of positive 
selection [21]. 
To minimize the effect that dead cells may have on the selection process the SELEX 
cellular suspension is typically evaluated for the presence of dead cells prior to incubation with 
the library [ 6]. The number of dead cells can be quickly estimated using a propidium iodide (PI) 
stain and flow cytometry analysis. Dead cells will pick up the PI stain resulting in a fluorescent 
signal around 61 7 nm, while the living cell membrane is impermeable to PI [22]. The general 
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recommendation is that no more than 5% of dead cells should be present within the SELEX 
selection suspension. This stringency in dead cell count applies to both the positive and negative 
selection steps of the cell-SELEX procedure [20]. 
One approach for dealing with the high amount of uptake of non-specific sequence by 
dead cells is the use of fluorescence-activated cell sorting (F ACS). This method relies on the 
separation of living and dead cells based on their light scattering characteristics. Following the 
incubation of the SELEX library with target cells, cells are sorted based on their light scattering 
characteristics using FACS. The living cells are then collected, and tightly bound sequences from 
these cells are eluted and amplified for future rounds. While this method is appealing, it still 
presents the challenge of potential aptamers being lost due to uptake by dead cells prior to 
sorting and sequences lost during the negative selection portion of SELEX. In addition, F ACS 
requires expensive equipment, which is not required for traditional cell SELEX methods [1 O]. 
1.2.2.1 Masking DNA 
To overcome the challenges of non-specific binding of sequences to the complex cell 
surface, as well as non-specific uptake of DNA by dead cells, masking DNA (mDNA) is used in 
the form of primer-free single stranded DNA (ssDNA) [18], yeast tRNA [17], salmon sperm 
DNA [10, 23], or genomic DNA[24]. Unlike the sequences present within the SELEX library, 
masking DNA lacks primer regions and as a result will not be amplified during the PCR 
amplification of sequences collected at the end of a round of selection [5]. 
Masking DNA present within the SELEX suspension will compete with low affinity 
binders and nonspecific binders for targets while allowing high affinity sequences to bind with 
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their unique targets. This results in and increased stringency in the selection process leading to 
improved efficiency demonstrated by a decrease number of necessary SELEX rounds. In 
addition the masking DNA in solution will act as a substrate for any nuclease enzymes and 
decrease the number of library sequences being digested [ 5]. 
To allow for maximum benefit of masking DNA present within the SELEX suspension, 
it must be as similar to the selection library as possible. This similarity increases the ability of 
the masking DNA to outcompete the library at non-specific sites. The optimal masking DNA is 
than an oligonucleotide sequence identical in length to the random region of the selection library 
without primer portions. It is selected at random, contains a 1: 1 CG to AT ratio and cannot bind 
to the library primer regions to eliminate amplification during PCR [5]. 
Previous cell SELEX procedures in our lab, as well as others, have chosen the 
masking DNA concentration arbitrarily. To date no model existed that could be used to 
characterize the interaction of masking DNA and library sequences with target cells. Typically, 
masking DNA is present in significant excess to the library concentration. The concentrations of 
masking DNA vary anywhere from 5 to 100 times that of the library [10, 17, 18, 23, 24]. 
1.2.3 PCR amplification 
Once target bound sequences are collected they need to be amplified by PCR and 
prepared for the following round of selection [ 1]. PCR is a process, which allows for the 
exponential amplification of nucleic acids. In brief, PCR consists of three repetitive steps: 
denaturation of the target sequence, annealing of the primer regions to the single stranded 
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denatured template and the extension of a nascent strand starting from the double stranded 
primer site [25]. 
DNA polymerases cannot synthesize a complimentary strand purely from a single 
stranded template but instead requires a double stranded segment of DNA [25]. In vivo these 
double-stranded initiation points are provided by the creation of Okazaki fragments [26]. During 
in vitro PCR amplification, primer regions function as Okazaki fragments allowing for 
transcription to occur. Primers, short sequences complimentary to the terminal ends of the 
template, are added to the PCR mixture and hybridize with the terminal ends of template 
sequences providing the start-off point for new strand synthesis [25]. 
The accurate annealing of primer regions to the desired template is what controls the 
specificity of a PCR reaction. When primers bind with high specificity only to the terminal 
template regions, specific products are synthesized [26]. By products are created when 
hybridization occurs between primer-template (non-terminal area), template-template and 
primer-primer sequences [27]. 
During the amplification of potential aptamers it is important to maintain PCR 
specificity, reducing the creation of any potential byproducts. During cell-SELEX PCR, 
byproducts can result from two main sources: the non-specific amplification of library sequences 
[27] and the amplification of genomic DNA that has been released by target cells and collected 
along with potential aptamers [28]. 
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1.2.3.1 Library byproduct formation 
The amplification of a heterogeneous pool of oligonucleotides comes with the increased 
risk of byproduct formation as compared to a homogenous sequence [27]. Byproduct formation 
of heterogeneous pools of nucleic acids is due primarily to product-product hybridization, or 
template-template hybridization. When two ssDNA sequences hybridize to one another they 
provide the dsDNA starting point that is required by Taq polymerase to begin the extension 
process [25]. Therefore, when two template strands hybridize to one another the product that will 
form will not be a perfect copy of either of the initial templates but will be an undesired 
byproduct [2 7]. 
Previous work in our laboratory explored the process of byproduct formation within a 
heterogeneous nucleic acid pool. It was shown that the amplification of heterogeneous pools of 
DNA in the low pM range resulted in the formation of significant byproducts within 20 cycles 
and by 25 cycles all sequences had been converted to byproduct segments. This high production 
of byproducts occurred despite the fact that significant primers remained available within the 
PCR mixture, suggesting that as the amount of product increases so does the risk of product-
product hybridization and subsequent byproduct formation. Furthermore, it was shown that as 
the complexity, with respect to the number of unique sequences, of the initial nucleic acid pool 
increases so did the risk of byproduct formation [27]. 
The template concentration is also an important factor that limits the specificity of a PCR 
reaction. The amplification of target sequences typically plateaus in the nM range after which 
byproducts begin to form and template sequences are lost from the suspension. While the exact 
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mechanism is unknown, the over-amplification of target sequences results in their degradation 
into smaller byproducts [29]. 
Byproduct formation is a major problem during the cell SELEX procedure since the 
stating pool of DNA is very complex, consisting of as many as 1015 unique sequences and the 
concentration of bound sequences collected during the first several rounds of selection is high 
[ 6]. At the start of selection the heterogeneity of the target bound sequences is very high and is 
greatly reduced in subsequent rounds as selection progresses. In order to ensure that all potential 
aptamer sequences collected in the initial SELEX rounds are accurately amplified and remain in 
the selection pool the number of byproducts formed must be minimized. 
1.2.3.2 Amplification of genomic DNA 
During the process of cell-SELEX, the collection of bound library sequences is often 
done through heating of the SELEX mixture, typically to 95°C [6]. Heating the SELEX 
suspension to such an extent causes cell lysis resulting in the ejection of genomic DNA from the 
cell [28]. The mixture is then spun down and the supernatant is collected. In the end, the 
supernatant will contain both library sequences that had bound to the target as well as genomic 
DNA. Library sequences contain primer regions, permitting them to be amplified during the PCR 
procedure [29]. Despite the fact that genomic DNA does not contain primer sequences, it still 
holds the potential to be amplified through various levels of annealing to either the primers or to 
library sequences present in suspension. Once genomic DNA anneals with another sequence the 
double stranded starting point for Taq polymerase extension is created. This in tum results in the 
production of non-specific sequences as well as in the consumption of PCR materials [28]. 
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1.2.3.3 Annealing temperature 
The hybridization of primer regions to their target occurs through complimentary base 
pairing between the nucleic acids and is dependent on the temperature of the reaction. The lower 
the annealing temperature of a PCR reaction mixture the easier base pairs will form between two 
ssDNA sequences that are not perfect base-pairing compliments of one another [25]. Using an 
annealing temperature that is too high will result in a very low number of primers being able to 
anneal to their target sequences causing a decrease in amplification efficiency. On the other 
hand, setting the annealing temperature too low will result in base pairing of primers to their 
targets (with a perfect base pair match) as well as potentially to other undesired sequenced. 
Furthermore, setting the annealing temperature too low will also result in the reformation of 
double stranded DNA templates making them inaccessible for primer hybridization and thus 
amplification [25]. 
Typically the annealing temperature is selected based on the melting temperature (Tm) of the 
primer sequences used. This melting temperature can be estimated using a variety of 
mathematical formulas [25]. The simplest formulas are based mainly on the length and GC 
content of a primer sequence. More complex formulas consist of several PCR reaction 
parameters including the Na+ ion concentrations and base-stacking effects [30]. Since primers are 
typically purchased commercially, most companies provide an accurate Tm as part of the 
specification sheet eliminating the need to determine it experimentally or mathematically. For 
the majority of cell SELEX procedures the annealing temperature is set to just above 
(approximately 5°C) the Tm of the primer sequences [25]. 
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1.3 Aptamer applications 
Aptamers are selected for a wide variety of applications ranging from in vivo to in 
vitro and from research to clinical settings. To date aptamers have been used for imaging, assays, 
drug targeting, and as drugs themselves [31, 32]. Aptamers provide several advantages compared 
to their closest counterparts, antibodies. Aptamers show low immunogenicity, are easy to 
synthesize, are relatively easy to amplify and can be selected against virtually any target using an 
established in vitro method of selection [ 1]. 
1.3.1 In vitro 
In vitro application of aptamers ranges from assays to cell typing. Aptamers are ideal 
candidates for assay development due to the fact that they can be easily modified and are quite 
resilient in a variety of conditions [33]. Aptamer-based assays have been developed against a 
wide range of targets from anthrax spores [28] to ATP [34] to cocaine [35]. Aptamer based 
assays can be designed based on a variety of detection methods including fluorescence, 
electrochemistry, nano-labels and nano-constructs [33]. A fluorescence based aptamer assay for 
cocaine was able to detect levels as low as 1 µM, making it a useful technique for cocaine 
detection in serum, plasma and urine [35]. Aptamers selected against anthrax spores were tested 
as potential candidates for assay detection of anthrax contamination and could be extremely 
useful in applications relating to biowarfare [28]. 
Recently, several aptamer based diagnostic assays have been published demonstrating the 
application of aptamer affinity and specificity for the detection of pathogens. In a paper 
published by Duan et. al. it was shown that an assay could be developed using aptamers 
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conjugated to magnetic nanoparticles to detect less than 1 Ocfu/ml of either Salmonella 
Typhimorium or Staphylococcus aureus [36]. Such an assay would be beneficial in identifying 
contamination of water or food as well as potentially diagnosing patient infections [36]. 
Over the years both cell-SELEX and other forms of SELEX have generated a wide 
variety of aptamers against cell membrane proteins, especially against cancer cell lines [37]. 
Recently these aptamers have been used to develop an aptamer-based cell typing approach. 
Seven aptamers were used to try and evaluate the cell surface proteome of 14 different cell lines. 
While some aptamers worked well in identifying cell proteins accurately, others showed a less 
than ideal level of specificity for their target, suggesting that further research is needed in 
developing improved aptamers that show not only high affinity but also a high level of 
specificity for their target [38]. 
1.3.2 In vivo 
Much like in vitro applications, in vivo applications of aptamers vary widely including 
imaging [39], drug delivery and therapeutics [40]. The idea that aptamers could be used as drugs 
was suggested in the 1990's with the selection of sequences against RSV. The RSV-specific 
aptamer showed not only high binding affinity and specificity but also caused a decreased level 
of infection of viral particle to their targets in cell culture [ 15]. Antiviral effects of aptamers were 
again demonstrated by Wang et. al. when SELEX generated sequences were able to diminish the 
infection rate ofHCMV particles [14]. 
Several therapeutic aptamers have transitioned from the research world into clinical trials. 
The aptamer AS 1411, which targets the membrane bound protein nucleolin was introduced into 
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clinical trials in 2005 [ 41]. Results of the clinical trials have varied and the progression of 
AS 1411 as a therapeutic agent against human cancer has not been seen. On the other hand, 
aptamer pegaptanib, which targets vascular endothelial growth factor (VEGF), successfully 
underwent clinical trials for the treatment of macular degeneration [42]. Currently the aptamer is 
marketed as Macugen by Pfizer as a drug for the treatment of macular degeneration [1]. 
Aptamer-based in vivo imaging dates as far back as 1997 when Charlton et. al. 
successfully used aptamers to image sites of inflammation by linking the Tenascin-C aptamer 
with a radiation imaging probe [43]. Fluorescence based whole body imaging has been used in 
conjunction with aptamers most frequently within the field of cancer research. In 2006 Hicke et. 
al. used aptamers linked to a fluorescent imaging probe to allow for the visualization of glial 
blastoma within a mouse model [44]. Since then several works have been published showing the 
wide application of aptamers as fluorescent targeting probes to further research in tumor 
development, pathogenicity and drug delivery [ 45] . 
The ability to combine aptamers with a wide variety of imaging probes allows 
researchers and clinicians to not only monitor disease processes directly in a living organism, but 
also to improve the treatment of diseases through improved pharmacokinetics [ 45]. In recent 
years several studies have shown that their ability to be conjugated to anything from a 
polyethylene glycol (PEG) molecule to a wide variety of nanoparticles makes aptamers very 
appealing tools in the field of theragnostics. As theragnostic targeting agents, aptamers are able 
to bind with high affinity and specificity to their target cells thereby directing imaging probes 
and/or the desired drugs to the cell/tissue of interest. To date, this has mainly been done in mice 
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model systems with promising results [ 46-48] Several studies have shown that using aptamers as 
targeting agents for imaging probes and drugs alike improves treatment outcomes f 46-48]. 
1.4 Research objectives 
This research project focused on two main objectives aimed at improving the process of 
aptamer selection against whole cells. The first objective of this project was to assist in building 
and subsequently testing a mathematical model that could be used to determine the appropriate 
masking DNA concentration needed for the selection of aptamers against living cells. The 
second objective was to modify the PCR amplification procedure for target-bound sequences 
collected during SELEX to decrease the effects of genomic DNA amplification and to reduce the 
formation of byproducts within the PCR mixture. 
1.4.1 Masking DNA model 
The advantages of using masking DNA, in aptamer selection, have been evident for 
several years [18]. To date, the concentration of masking DNA has been chosen arbitrarily. In 
response, our lab developed a mathematical model that could be used to determine the optimum 
concentration of masking DNA, within a cell SELEX mixture, that would outcompete library 
sequences by a certain number of times. This mathematical model was based on the experimental 
determination of the average EC5o of target cells for both the library and the masking DNA 
sequences [5]. 
I successfully tested this model using two different cell lines: MCF-7 human breast 
cancer and 4Tl mouse breast cancer. Using a commercially acquired ssDNA library and ssDNA 
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masking DNA sequence, it was shown that the mathematical model fit both the MCF-7 and 4Tl 
cell lines and could successfully be used to determine the concentration of masking DNA needed 
to outcompete the non-specific binding of library sequences at a desirable ratio [5]. 
1.4.2 Cell-SELEX optimization 
1.4.2.1 Decreasing effects of genomic DNA amplification 
As mentioned above (see section 1.2.1), heating the cell mixture to 95°C for several 
minutes, followed by centrifugation, achieves the elution of cell-bound library sequences. The 
supernatant is then collected and amplified via PCR. Unfortunately the resulting supernatant 
contains both library sequences and genomic DNA. This genomic DNA, despite lacking primer 
regions, can also be amplified during the PCR procedure. 
Using the 4T1 murine breast cancer line I attempted several rounds of cell SELEX. 
Analysis of PCR products suggested that large (> 300bp) sequences were contaminating the 
library pool. As selection progressed the amount of genomic DNA amplified increased and 
eventually surpassed the amplification of potential aptamer sequences. To reduce the effects of 
genomic amplification on cell-SELEX two main approaches were attempted. The first approach 
was the purification of the PCR products by slab-gel electrophoresis followed by gel extraction 
purification. This resulted in a significant decrease in PCR product and a potential for aptamer 
loss. As an alternative to gel purification, touch-down PCR was attempted to increase the 
specificity of the reaction by decreasing the likelihood of primers or library sequences annealing 
to genomic DNA and resulting in non-specific amplification. This resulted in a virtual 
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elimination of genomic DNA amplification while still resulted in a sufficient amount of library 
amplification. 
1.4.2.2 Improving PCR specificity 
Byproduct formation during the amplification of collected sequences is prevalent due to 
the heterogeneity and high concentration of the templates. Both of these factors contribute to a 
lower PCR specificity and result in the formation of byproducts. Byproduct formation is 
especially evident during the first several rounds of cell-SELEX when heterogeneity is at its peak 
and the number of sequences collected following target cell incubation is high. 
To simultaneously decrease the heterogeneity and the concentration of target bound 
sequences a modified aptamer selection procedure was attempted. The traditional cell-SELEX 
approach was combined with a non-SELEX method for the first two rounds of selection. The 
consecutive incubation steps, without amplification of sequences in between, resulted in a 
decrease in the sequence concentration and heterogeneity. When the concentration of collected 
sequences reached a pM range it was amplified via PCR with an improved specificity as 
compared to the traditional cell-SELEX approach. Non-SELEX rounds were subsequently 
followed by the traditional cell-SELEX protocol. 
CHAPTER 2: MASKING DNA IN CELL-SELEX 
2.1. Introduction 
Adapted with permission from Cherney, L.T., N.M. Obrecht, and S.N. Krylov, Theoretical 
Modeling of Masking DNA Application in Aptamer-Facilitated Biomarker Discovery. Analytical 
chemistry, 2013. 85(8): p. 4157-4164. Copyright 2013 American Chemical Society. 
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The goal of cell-SELEX is to identify ssDNA sequences, within a random library, that are 
capable of binding with high affinity to a unique target on a specific cell's surface (in contrast to 
a ubiquitous target such as a glycolipid). By identifying sequences that are capable of binding 
strongly and exclusively to a target cell, one can use them as targeting agents for both clinical 
and research purposes. To efficiently isolate aptamers from other library sequences we need to 
be able to collect and preferentially amplify (through PCR) the aptamer sequences while 
minimizing the number of non-specific sequences collected. 
Aptamer selection through cell-SELEX faces two major obstacles: the non-specific 
uptake of ssDNA sequences by dead cells and the non-specific binding of ssDNA sequences to 
the diverse cell surface [21]. Dead cells are always present, to a certain degree, within a cell 
suspension. It has been previously shown that the membrane of a dead cell becomes increasingly 
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Figure 2.1 A representation of a cell-SELEX incubation mixture consisting of target cells, 
masking DNA and library sequences both specific and non-specific. The top right inset provides a 
zoomed in view of the cell surface made up of specific and non-specific binding sites. 
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permeable, resulting in non-specific uptake of oligonucleotide sequences [10, 21]. 
At the same time, the living cell surface contains a large variety of proteins and other 
molecules present in thousands of copies [20]. Many of these molecules are capable of binding 
ssDNA sequences, typically in a weak, non-specific manner. This large amow1t of non-
specifically bound sequences translates to an increase in the number of selection rounds 
necessary to obtain a high affinity aptamer pool. In addition, the collection of non-specific 
sequences along with potential aptamers means that the sequences will compete for PCR 
reagents resulting in a decreased number of high affinity sequences being amplified successfully 
[5]. 
One way of improving the collection and amplification of aptamer sequences is through 
the use of masking DNA (mDNA). Masking DNA is a scrambled sequence of nucleotides, which 
lack primer regions and as a result will not be amplified during PCR. Various types of masking 
nucleic acids have been used in the past, ranging from ssDNA sequences [ 18] to salmon sperm 
[10] to yeast tRNA [17]. The masking sequence is added to the cell suspension along with the 
selection library as shown in Figure 2.1. The addition of mDNA along with the DNA library 
during the aptamer selection process leads to increased efficiency, sensitivity, stability and 
stringency of the cell-SELEX procedure. 
It is important to be able to optimize the mDNA concentrations needed for the most 
efficient aptamer selection procedure. The addition of too much mDNA, early on in the selection 
process, could result in a loss of aptamers from the collected fraction (at the end of a round of 
selection). This loss of aptamer occurs if the mDNA sequences are present in such high 
concentrations that they are able to out-compete even medium to high affinity library sequences. 
25 
At the same time if too little mDNA is added a large amount of non-specific library sequences 
will be collected. This will result in an increase in the number of rounds needed to isolate 
aptamers and a decrease in PCR amplification, which works best using pM template 
concentrations. 
2.2. Mathematical model 
Previous cell-SELEX procedures have employed masking oligonucleotides but their 
concentration was chosen arbitrarily. We set out to create a mathematical model that could be 
used to describe the interactions within a cell-SELEX mixture, and to use this model to 
determine the optimal amount of masking DNA for cell-SELEX [5]. 
The number of aptamer sequences in a given library is small, since the odds of having 
sequences binding with high affinity and specificity to a unique target are very low. The large 
majority of sequences are non-specific. As a result, following an incubation of the library with 
target cells, the majority of DNA collected will be non-specific. The challenge is to be able to 
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Figure 2.2 A schematic representation of the masking DNA model, where the masking 
DNA outcompetes non-specific library sequences at non-specific binding sites but is unable 
to outcompete specific sequences to specific sites due to their increased affinity [ 5] 
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separate specific sequences from non-specific sequences as efficiently as possible in the least 
number of rounds. When masking DNA is added into the suspension, it binds to the non-specific 
sites, displacing the non-specific library sequences present in the SELEX suspension (Figure 
2.2). The aptamer sequences bind tightly to their unique targets and therefore are not displaced 
by the non-specific masking DNA. When sequences are collected at the end of a round the 
resulting pool contains a small number of aptamers, a large number of masking DNA sequences 
and decreased number of non-specific library sequences [5]. 
The cell-SELEX mixture can be simply described as consisting of the following 
components: aptamers (A), non-specific sequences within the selection library (Lns), cells (n), 
specific binding sites (Ns) and non-specific binding sites CNns)· The interactions that occur within 
a cell-SELEX mixture are complex and difficult to solve mathematically therefore, they were 
simplified based on two main assumptions: A<< Lns and Ns << Nns· Based on these assumptions 
the typical type of interaction that occurs in a cell SELEX mixture is non-specific ssDNA 
sequences from the library pool, or masking DNA (M), binding at non-specific binding sites. 
Therefore, the majority of interactions occurring on the cell surface within the cell-SELEX 
mixture can be characterized by two dissociation constants K and K which are defined as 
nsL nsM 
the ratio of non-specific sites occupied by non-specific library sequences and masking DNA 
respectively. 
K L and K M can be combined using the relationship constant kappa ( K), which is 
ns ns 
defined as the ratio by which the masking DNA sequences outcompete the library sequences at 
non-specific sites. An equation was derived (equation 1) that allows for the calculation of the 
initial masking DNA concentration (Mo). The mDNA concentration is determined based on the 
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desired K valued and other experimental parameters of the cell-SELEX procedure [5]. 
Mo = KKnsMLO + (1- KnsM J KnSNLo 
KnsL KnsL KLo + KnsL (1) 
K >> 1, KL0 >> nSN 
Majority of parameters within equation (1) are dictated by the experimental setup: Lo 
(initial library concentration), n (number of cells in solution), S (estimated cell surface area in 
cm2) and K. However, KnsM, N (number of binding sites) and KnsL must be determined 
experimentally. The unknown parameters can be determined by measuring the binding affinity of 
library and masking DNA to target cells. The binding affinity of sequences to target cells cannot 
be described by a dissociation constant due to the complexity of interactions and unknown 
stoichiometry. Typically, when stoichiometry is unknown binding affinity can be estimated 
using EC50 values (equilibrium concentration at 50% of maximum binding). By measuring the 
EC50 at an increasing concentration of cells (for both the ssDNA library and masking DNA) we 
can plot the relationship of EC so versus cell concentration and fit by linear regression analysis. 
The line of best fit will correspond to equation 2, from which the slope and y-intercept provide 
us with the values ofN and Kd respectively [5]. 
1 
EC50M = -nSN +KnsM' 
2 
1 
EC50L = - nSN + KnsL 
2 (2) 
The masking DNA concentration required can be determined by introducing both of the 
Kd values and the average N value into equation 1 along with the experimentally defined 
parameters. 
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2.3. Choice of experimental model 
The mathematical model was tested against two different cell lines (MCF-7 and 4Tl) using 
the same random library and masking DNA sequence (see Materials and Methods). 
2.3.1. MCF-7 human breast cancer 
The first model system used to test our mathematical model was the human breast cancer 
cell line MCF-7. The MCF-7 cell line was established from a metastatic mammary carcinoma 
obtained from a pleural effusion clot in a female patient [ 49]. MCF-7 cells are mammary 
epithelial cells and have been used extensively in research since their initial establishment. The 
application of the MCF-7 cell line has ranged from in vitro studies where characteristics of 
cancer as well as cancer treatment modalities were explored [50]. In addition early on xenograft 
tumors of MCF-7 cells were established in athymic mice to allow for in vivo cancer research 
directly on a human cancer cell line within a model system [51]. 
This widespread use of MCF-7 cells makes them desirable targets for aptamer selection 
through cell-SELEX. While several aptamers have been developed to purified epitopes found on 
the MCF-7 membrane [38], the cell line itself has never been used for aptamer selection. Testing 
our masking DNA model with such a widely used cell line is of great potential value for any 
future cell-SELEX based aptamer selection that may be performed against MCF-7 cells in the 
future. 
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2.3.2. 4Tl mouse breast cancer 
The second cell line tested was the murine breast cancer cell line 4T1. The 4T1 cell line 
is also a tumorigenic mammary epithelial cell line. Development of graft 4Tl tumors in mice 
closely mimics the development of tumors in humans. This similarity makes 4Tl a very useful 
and widely used research model system [52]. To date numerous pre-clinical studies have been 
done, paving the way for potential new treatments and metastasis prevention using 4Tl tumors 
[53]. 
Aptamers have been selected through traditional SELEX that show high affinity and 
specificity for epitopes found on the 4Tl cell surface [54]. However, the cell line, despite its 
widespread use has not been subjected to cell-SELEX directly. The application of our masking 
DNA model against the 4Tl cell line not only improves any future aptamer selection against the 
cells but also demonstrates the robustness of our model for a range of cell lines across species. 
2.4. - Materials and methods 
2.4.1. DNA sequences 
DNA sequences were purchased from IDT (Coralville, IA, USA). All DNA used was 6-
carboxyfluorescein (F AM)-labeled at the 5' end. The masking DNA sequence was generated at 
random and modified to ensure no complimentarity with the library primer regions (5' -FAM/ AA 
GGG TCC TGT GCT ATA ACT GTG GGT CTA GTG GTA TTT AG-3'). ssDNA library 
consisted of a 40-nt random region flanked by 20-nt-long primer regions (5'-FAM/AGC CTA 
ACG CAG AAC AAT GG-random region-CGA TGC CAG GTT AAA GCA CT-3'). 
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2.4.2. Cell cultures 
MCF-7 cells were grown in the Dulbecco's Modified Eagle medium with high glucose 
content (DMEM/HG, catalog #D5796, Sigma- Aldrich, St. Louis, MO, USA) with 10% fetal 
bovine serum (FBS, catalog #SH30396.03, HyCyclone Laboratoried, Logan, UT, USA) and 1 % 
100 U/mL penicillin-streptomycin (penicillin-streptomycin solution catalog #P4333, Sigma-
Aldrich, Oakville, ON, Canada) at 37 °C in humidified 5% atmosphere. Cells were sub-cultured 
24 hours prior to cell-suspension preparation. 
4Tl cells were grown in RPMI 1640 medium (catalog# 30-2001, ATCC, Manassas, VA, 
USA) with 10% fetal bovine serum (FBS, catalog #SH30396.03, HyCyclone Laboratories, 
Logan, UT, USA) and 1 % 100 U/mL penicillin-streptomycin (penicillin-streptomycin solution 
catalog #P4333, Sigma- Aldrich, Oakville, ON, Canada) at 37 °C in humidified 5% atmosphere. 
Cell diameter of both cell lines was estimated using bright field microscopy calibrated by a stage 
micrometer grid and was in agreement with previously determined values for both cell lines. 
2.4.3. Determining ECso 
Plates were rinsed twice with Dulbecco' s phosphate buffered saline (PBS, catalog 
#D8537, Sigma-Aldrich, Oakville, ON, Canada), and cells were detached using 0.05% Trypsin 
(Trypsin-EDTA Solution IX, catalog #59417C, Sigma-Aldrich, Oakville, ON, Canada) at 37 °C 
for no more than 1.5 minutes to minimize the degradation of cell surface proteins. Cells were 
then re-suspended in DMEM/HG or RPMI 1640 (for MCF-7 and 4Tl cells respectively), 
counted via hematocytometer, and spun down for 5 min at 300g and 4 °C. Medium was 
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discarded, and cellular pellet was re-suspended in PBS + 5 mM MgCh to the desired 
concentration (1 to 5 cells per 1 nL). 
Masking DNA and library sequences were diluted to 1 OOµM concentration in PBS. Prior 
to incubation with target cells, masking DNA and library sequences were heated at 95°C for 5 
minutes and then snap cooled on ice to allow for the formation of stable three dimensional 
structures. 
Cell suspension was aliquoted into 500 µL samples. Prior to the addition of nucleic acids 
a single aliquot of target cells was tested for percent cell viability. Target cell suspension was 
incubated with 1 µL of lmg/ml propidium iodide (Pl) for 5 minutes at 37°C. Following 
incubation cells were analyzed via flow cytometry for 15 000 - 30 000 events (depending on cell 
concentration). Number of dead cells was determined by looking at the number of events with a 
fluorescence signal of 105 or higher with the PerCP-Cy5-5-A filter. Suspensions containing 
greater than 5% dead cells were discarded. 
Suspensions with :::; 5% dead cells were incubated with increasing concentrations of 
masking DNA or library DNA for 30 to 60 min at 37 °C while gently shaking. Cells were then 
analyzed by flow cytometry for 30 000 events (except 1 cell/nL suspension which was analyzed 
for 10 000 events to avoid a large variability in analysis time between different cell 
concentrations). Mean fluorescence signal was obtained for each masking DNA or library DNA 
concentration from 1 OnM until a saturation point was reached based on a lack of increase in 
fluorescence. 
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Figure 2.3 The binding affinity curve of 1 million MCF-7 cells incubated with increasing masking 
DNA concentrations and analyzed by flow cytometry. The ECso value, demonstrated by the red 
solid line, is the point at which half the maximum fluorescence signal is reached. 
A binding affinity curve was generated by plotting DNA concentration versus mean 
fluorescence signal, and the EC5o was determined by locating the DNA concentration at which 
half of the maximum fluorescence signal was reached. For each cell line ECso values, for both 
the library and masking DNA experiments, were plotted versus cell concentration and a line of 
best fit and its representative equation were obtained through Excel, Microsoft Office based on 
the least squares model. 
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2.5. Results and discussion 
2.5.1. MCF-7 cell line 
The mathematical model was first tested using MCF-7 cells. The ECso values were 
obtained for a range of cell concentrations from lcell/nL to 5 cells/nL. To determine ECso values 
at various cellular concentrations binding curves were obtained based on library or masking 
DNA fluorescence. The binding curves were created using excel and the EC5o value was 
determined manually as the point at which 50% of the maximum fluorescence was reached 
(Figure 2.3). The average cell diameter was measured by light microscopy and equal to 2.5x10-
3 cm, resulting in an average surface area of 2x10-5 cm2 based on the equation of the surface area 
of a sphere. 
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Figure 2.4 The dependence of EC5o on cell concentration for the masking DNA and library 
incubated with MCF-7 cell lines. With the masking DNA line of best fit represented by the 
equation y = 0.05x + 0.48 and library line of best fit y = 0.054x + 0.566. 
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As predicted by the mathematical model, and shown in Figure 2.4, the EC50 values 
increased with increasing cell concentration for both the masking DNA and library samples [5]. 
The line of best fit was calculated using the least squares model on Microsoft Office Excel. 
Overall the fit of the line, to the experimentally obtained data points, was much better for the 
library than the masking DNA with R2 values of 0.87 and 0.42 respectively. 
It is important to note that MCF-7 cells are known to aggregate in suspension [ 49]. Large 
cellular aggregates present a challenge in two different ways. The first challenge is in obtaining 
an accurate cell count during cell suspension preparation. Very large aggregates are formed 
making accurate cell counting difficult. Accurate counting was especially challenging with 
increased cell concentrations. To decrease the influence of a single inaccurate count, counts were 
done in triplicate and an average was taken. 
The second challenge lay in the analysis of cells following incubation. The suspension is 
passed through a cellular filter, with a pore size of 45µm, to break up large aggregates prior to 
flow cytometry analysis. However, cells in small groups of two or three are still be able to pass 
through the filter. Two or three cells adhering to one another result in a decrease in the number 
of binding sites available to the nucleic acid sequences present in suspension. The combined 
effect of inaccurate cell counts and cell clusters resulted in a decrease in the accuracy of 
experimental data. 
The average Kd values for both the masking DNA and the library to binding sites on the 
target cell surface, based on the y-intercept of the best fit line in Figure 2.4, were determined to 
be 0.56 ± 0.15 µMand 0.48 ± 0.07 µM respectively. The close proximity of the two values 
suggests that, on average, both the library sequences and the masking DNA sequence have a 
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similar affinity for non-specific sites on the MCF-7 cell surface. Specific aptamers, selected 
through cell-SELEX, typically have EC5o values in the high pM to low nM range. Since the 
library sequences and masking DNA should show predominantly non-specific binding, the 
obtained µM EC5o values are as expected [5]. 
The number of binding sites (N) was calculated based on the slope of the best-fit line, 
which was equal to 0.2nSN. N values were determined to be 5.7x 10-12 mol/cm2 and 5.1 x 10-12 
mol/cm2, for the masking DNA and library respectively. The average number of binding sites 
was determined to be 5.4 ± 0.14 x 10-12 mol/cm2• The fact that the number of binding sites 
determined was similar, confirms that our model assumptions of non-specific binding to the 
same binding sites for both masking and library DNAs is valid. Furthermore, a crude estimate of 
the average binding site size was determined, using surface area (S) estimate and the 
experimentally determined number of binding sites, to be 3.1 x 103 A2 where we used the 
average value of N = 5.4 x 10-12 mol/cm2 found from EC50 measurements for both library and 
masking DN As. The obtained value of 3 .1 x 103 A 2 is sufficiently high to allow both library 
DNA and masking DNA to bind the cell surface with all their nucleotides. In this case, the 80-nt 
long library ssDNA would occupy......, 3 x 103 A2 and the 40-nt long masking ssDNA would 
occupy half of this area [ 5]. Since aptamers fold into complex three-dimensional structures this 
type of binding is not required and likely does not occur during cell-SELEX. In addition, the 
target cell surface area is estimated using the cellular radius and the formula for the surface area 
of a sphere. While this provides a crude estimate sufficient to serve our purposes it is a gross 
underestimation of the actual available binding surface. Curvatures and folds in the membrane 
increase the binding surface area significantly. 
36 
2.5.2. 4Tl cell line 
To confirm the accuracy of our model, experiments were repeated with the mouse cell 
line 4Tl. All testing was done with identical DNA sequences and experimental procedures. The 
resulting EC50 values were plotted versus the cell concentration and are provided in Figure 2.5. 
The average dissociation constants and number of binding sites were determined based on 
equation 2 for both the masking DNA and library sequences. 
Unlike MCF-7 cells, 4Tl cells do not have a tendency to aggregate making them both 
easier to count and to accurately analyze via flow cytometry. This is reflected in the increased R2 
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Figure 2.5 The dependence of EC5o on cell concentration for the masking DNA and 
library incubated with 4Tl cell lines. With the masking DNA line of best fit represented 
by the equation y = 0.2x + 0.78 and library line of best fit y = 0.054x + 1.24 
values of 0.88 and 0.99 for the masking DNA and library respectively (Figure 3.3). The Kd 
values for the masking DNA and library were 0.78µM and l.24µM respectively. The lower Kd 
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value of the masking DNA sequence, versus the library, suggests that the masking DNA 
sequence may have had a specific target to which it had a slightly higher affinity than the 
average library sequence. 
The number of binding sites (N) for masking DNA and library were detennined to be 
N = 2.2 x 10-10 mol/cm2 and N = 4.8 x 10-11 mol/cm2 respectively. The average number of 
binding sites was determined to be 1.35 ± 0.61 x 10·10mol/cm2• The 4Tl cell line showed an 
increase in the number of binding sites between the library and masking DNA versus the values 
obtained using MCF-7 cells. However, for masking DNA and library sequences the N values 
were within an order of magnitude. Furthermore, the fact that the masking DNA sequence is half 
the length of the library sequences (due to lack of primer regions) implies that it may be able to 
bind to a greater number of epitopes based on size alone. This variation between masking DNA 
and library sequences may not have been as evident with the MCF-7 cell line due to the variation 
in R 2 values between the two sequence types. 
2.6. Conclusions and future directions 
We introduced a simple mathematical model that describes the binding of library DNA 
(containing potential aptamers) and masking DNA to the cell surface. The model takes into 
account the high-affinity binding of aptamers to specific sites on the cell surface and the low-
affinity binding of library DNA and masking DNA to non-specific sites o·n the cell surface. 
Based on this model we developed a simple method for estimating the concentration of masking 
DNA required to out-compete library DNA at any desirable ratio, K, describing binding to non-
specific sites. Parameters K, L, n, and S are known from experimental conditions whereas 
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characteristics N, KnsL, and KnsM are not. We obtained theoretical relations allowing the 
determination of N, KnsL, and KnsM based on measurements of EC5o values for cells mixed 
separately with the library and masking DNAs [5]. 
The developed procedure was successfully applied to the MCF-7 breast cancer cell line 
and corresponding values of N, KnsL, and KnsM were established for the first time [5]. To 
demonstrate the robustness of the proposed model testing was repeated using the 4Tl cell line. 
Both cell lines resulted in the successful determination of all needed parameters to allow for the 
determination of the necessary masking DNA concentrations. The model was successfully 
applied to both cells despite the fact that the two cell lines vary significantly from their origin to 
their behavior within a cell-SELEX suspension. 
In future experiments, it would be beneficial to further evolve our model by determining 
the optimum value that would result in the most efficient cell-SELX procedure. This could be 
done simply by monitoring the progress of selection of several simultaneous cell-SELEX 
procedures at the same time, which differ only in the value used. 
The parameters determined for MCF-7 and 4Tl cell line can be applied to cell-SELEX 
for aptamer selection. Masking DNA concentrations can be calculated based on the experimental 
parameters and the desired kappa value. To increase the stringency of selection the kappa value 
can be increased as selection progresses. 
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CHAPTER 3: OPTIMIZATION OF 4Tl APT AMER SELECTION THROUGH 
INCREASED PCR SPECIFICITY 
3.1. Introduction 
3.1.1. Purpose of PCR in cell-SELEX 
During cell-SELEX, sequences bound to the target cells are collected and need to be 
accurately and efficiently amplified to be used for the subsequent round of selection. Aptamer 
sequences in the early stages of selection are present in single to low copies. To ensure that the 
aptamer sequence is maintained within the selection pool it must be amplified accurately and 
efficiently. To obtain accurate amplicons from a PCR reaction byproduct formation needs to be 
minimized. The creation of byproducts consumes PCR reagents and results in the potential loss 
of aptamer sequences from the selection pool. An inefficient and non-specific amplification of 
aptamer sequences collected through SELEX could greatly hinder the selection process [ 1]. 
3.1.2. Amplification challenges 
PCR amplification of cell-SELEX collected sequences faces two main challenges: the 
high level of heterogeneity of the template sequences, their high (nM) concentration [27] and the 
presence of genomic DNA [28]. Both of these challenges result in a need to optimize the PCR 
amplification of the desired sequences in order to ensure that accurate products are formed. 
The starting library pool typically consists of 1015 unique sequences [1]. This type of 
variety is necessary to ensure that high affinity aptamers, for the targets of interest, are present at 
the onset of selection. As a result the heterogeneity of template sequences in cell-SELEX PCR 
step is very high. While this heterogeneity decreases as selection progresses it remains 
significantly higher, when compared to standard PCR protocols, throughout the selection 
procedure with potentially hundreds of sequences present in the final round of selection [1]. 
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At the same time, due to the heating of cells during the elution process, genomic DNA is 
often ejected from the cell during lysis and is collected along with target bound sequences. 
Misannealing of primers to genomic DNA results in their amplification [28]. The amplification 
of genomic DNA results in a byproduct, decreasing the efficiency of selection. To decrease the 
amount of byproduct formation, from template sequences and from genomic DNA 
contamination, the specificity of the PCR reaction needs to be increased [25]. 
3.1.3. Traditional PCR approach 
The polymerase chain reaction was introduced into the laboratory setting in 1971, but did 
not become mainstream until the 1980's [55]. The reaction consists of three general steps: 
denaturation, annealing and extension. The specificity of the reaction is dependent on the 
annealing of primers to the primer regions of the template sequence [25]. 
3.1.4. Components and procedure 
Typically a PCR master mix is prepared consisting of four main components: buffer, 
forward primer sequence, reverse primer sequence, and dNTPs mixture. The forward primer 
initiates the synthesis of the sense sequence and the reverse primer initiates the antisense 
sequence. Symmetric PCR is performed when equal concentrations of reverse and forward 
primer are present and therefore dsDNA product is produced. Asymmetric PCR can be 
performed by adding a higher concentration of the forward primer compared to the reverse 
resulting in an increased production of the sense strand [29]. Master mix is then aliquoted into 
small vials and a thermostable polymerase, as well as a template sequences, are added. 
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Several repetitions, of the three PCR steps, results in the exponential amplification of the 
template sequence. The synthesized dsDNA strand consists of the sense (forward) strand 
identical to the template sequence( s) and anti sense (reverse) strand complimentary to the 
template sequence(s). For the purposes of cell-SELEX only the forward sequence is required, 
therefore a post-amplification clean-up is necessary to obtain a ssDNA pool of sequences. 
Clean-up of the antisense strand is typically done by biotin tagging the reverse primers, which 
results in a biotin labeled reverse strand that can be removed by binding to streptavidin resin 
[25]. 
3.1.5. Specificity control 
The stringency of the PCR reaction is guided by the accurate hybridization of the primer 
sequence to the primer regions of the template. Byproducts are created through the misannealing 
of primers-template, primer-primers, template-template and in the cell-SELEX mixture primers-
genomic DNA. To ensure that all potential aptamer sequences are amplified sufficiently and 
accurately the synthesis of byproduct needs to be minimized by improving PCR specificity. The 
specificity of a PCR reaction can be regulated by three main factors: salt (MgCh) concentration, 
additives ( eg. formamide, betaine) and annealing temperature. 
3.1.5.1.Magnesium ion concentration 
Commonly, MgCh salt is added to PCR mixtures. Magnesium ions within the PCR 
mixture act as a concentration dependent co-factor for thermostable DNA polymerase. The 
presence of magnesium ions stimulates polymerase activity and effects the quality and quantity 
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of the prodtlcts formed [ 56]. The concentration of magnesium within a PCR mixture ranges from 
0.5mM to 5mM and is dependent on the presence of other chemicals ( eg. ions, EDT A) and 
concentration of dNTPs. Since dNTPs are negatively charged they have the ability to bind the 
positively charge magnesium ion resulting in its overall depletion within the reaction mixture 
[25]. Other chemicals may be added to the reaction mixture through the addition of the template 
solution, which could contain EDT A or calcium ions added inadvertently during template DNA 
extraction. Much like dNTPs, such contaminants can affect the optimum magnesium 
concentration by either sequestering or competing with the Mg++ ions [56]. 
The concentration of salt can be carefully titrated for a given PCR master mix to improve 
the specificity of the reaction [57]. Commercial kits are currently available, which allow for the 
optimization of both salt and dNTP concentration for any given PCR reaction increasing the 
efficiency of the optimization process. However, even with the application of commercial kits 
optimization of salt and dNTPs concentration is still a fairly labor intensive and time-consuming 
procedure [25]. 
3.1.5.2. Additives 
Several additives are commonly used to improve PCR stringency. Most commonly these 
are in the form of detergents, solvents, reducing compounds or enzyme stabilizing agents [25]. 
Enhancing additives can be used in a wide variety of combinations or on their own to improve 
both the efficiency and specificity of a PCR reaction. Numerous commercially available kits can 
be purchased, which contain a pre-mixed enhancing solution. Such kits are typically relatively 
expensive and the components are not disclosed [58]. Alternatively, enhancing mixtures can also 
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be synthesized in house in the interest of saving money as well as having a clear description of 
the mixture's components. Either way the introduction of enhancer(s), either separately or in 
combination, requires rigorous optimization for any PCR reaction. The way one template and 
primer combination reacts to an enhancer additive may vary significantly from another [58]. This 
type of optimization is incredibly time consuming especially since several components need to 
be optimized for a single PCR mixture [57]. 
3.1.5.3.Annealing temperature 
Since the specificity of a PCR reaction is dependent on the annealing stringency of primer 
sequences exclusively to primer regions of the template, the annealing temperature is critical in 
controlling the quality of the PCR product. The annealing temperature is dependent on the 
melting temperature of the primer sequences with primer regions (Tm). Tm is defined as the 
temperature at which 50% of the primers in solution are annealed to complimentary primer 
regions and 50% are present as ssDNA [59]. This temperature can is dependent on several 
factors including primer length, GC content, salt and template concentrations. Several 
mathematical formulas exist that allow for the calculation of a Tm with varying levels of 
accuracy [25]. In addition Tm can be determined experimentally. Software is currently available, 
which is capable of quickly determining the Tm for a primer sequence taking into account a wide 
variety of variables [25]. 
In traditional PCR, the annealing temperature is set to 5°C above the Tm· For simple PCR 
reactions, using a known uncontaminated homogenous template mixture, this annealing 
temperature estimate results in a sufficiently stringent primer binding. On the other hand in the 
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case of a more complex reaction mixture, such as a heterogeneous pool of template sequences or 
the presence of other contaminants such as genomic DNA, the annealing temperature needs to be 
optimized experimentally. This is especially true when the template sequences are present in a 
complex mixture of unknown composition such as cell lysate. Without the optimization of the 
annealing temperature the risk of byproduct formation is very high [25]. 
3.1.6. Touchdown PCR 
As a solution to the labor-intensive and time consuming optimization of PCR reactions 
Don et. al. were the first to suggest the use of a touchdown PCR protocol [ 60]. Instead of 
determining the optimum annealing temperature for a specific PCR set-up, the touchdown 
approach uses a range of annealing temperatures. The touchdown PCR protocol consists of two 
components: touchdown amplification and standard amplification. During touchdown 
amplification the starting annealing temperature is set to 10°C above the typical annealing 
temperature (i.e. 15°C above primer Tm) for the first cycle and is decreased by 0.5°C or 1°C at 
every cycle thereafter. This is typically done for ten to fifteen cycles followed by standard 
amplification at a typical annealing temperature [ 60]. 
The touchdown approach provides an amplification advantage to specific sequences 
present with the reaction mixture. The increased annealing temperature of touchdown PCR 
decreases the likelihood that non-specific annealing will occur within the reaction mixture. A 
decrease in non-specific annealing of sequences translates directly into the decrease of byproduct 
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creation [57]. This means that during the touchdown procedure only target sequences will be 
amplified. As a result, by the time standard PCR amplification begins the number of specific 
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sequences will significantly outnumber any potential contaminants that may have been present 
within the reaction mixture [60, 61]. 
Increasing the annealing temperature by 10°C results in a significant decrease in PCR 
efficiency. To ensure sufficient product synthesis, touchdown amplification is followed by 
several cycles of standard amplification. During standard amplification the annealing 
temperature remains constant at approximately 5°C above Tm allowing for the exponential 
amplification of template sequences. The amount of byproducts that are formed as a result of the 
standard amplification will be insignificant compared to the concentration of target sequence 
amplicons [ 60]. 
3.1.7.Hot-Start PCR 
Touchdown PCR is often coupled with hot-start PCR to ensure maximum reaction 
specificity. In hot-start PCR an essential component (polymerase, primers, dNTPs or 
magnesium) is kept separate from the remainder of the reaction mixture. Once the mixture 
reaches a sufficiently high temperature (>90°C) the missing component is added and the reaction 
is allowed to proceed. This type of approach ensures that all non-specific annealing that may 
have occurred during the preparation of the reaction mixture, at lower temperatures, is 
dissociated through heating before non-specific amplification can occur [25]. 
3.1.8. Product analysis 
Following amplification, PCR products need to be analyzed to ensure the success of the 
reaction. Most commonly, during aptamer selection, DNA products are analyzed using 
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electrophoresis [25]. For the purpose of cell-SELEX, it is necessary to confirm that the length of 
the product formed matches the length of the initial library. The presence of dsDNA sequences 
smaller than the library sequences suggests primer-primer, template-template or primer-template 
byproduct formation [27]. On the other hand, the presence of dsDNA that is significantly longer 
than the selection library suggests the amplification of genomic DNA [28]. 
3.1.8.1.Slab gel electrophoresis 
Gel electrophoresis is a commonly used technique in the analysis of nucleic acid. There 
are two commonly used gels in electrophoresis: agarose and polyacrylamide gel (PAGE). Gels 
are created from agarose/polyacrylamide dissolved in a buffer solution. The 
agarose/polyacrylamide creates a dense polymeric network within the gel. The density of the gel 
is directly proportional the amount of polymer added. Gels are then placed in a buffer solution 
and samples are loaded into wells. An electric current is applied across the width of the gel 
inducing movement of the sample components. The smaller components are able to pass easier 
through the polymeric network and therefore migrate faster within the gel. This variable 
migration is what causes separation of sample components according to their size [62]. 
When double stranded DNA (dsDNA) is separated by gel electrophoresis the migration 
time of different dsDNA sequences is based predominantly on the length of the DNA strand. 
Once an electric field is applied dsDNA sequences are separate based on their size. If distinct 
groups of dsDNA (in terms of their length) are included within the sample, they will be separated 
into different bands according to their size. To visualize the dsDNA within the gel a fluorescent 
intercalating agent can be included in the run buffer. The intercalating agent (eg. ethidium 
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bromide) binds the double stranded sequences and its fluorescence can then be visualized using 
ultraviolet (UV) excitation. To determine the corresponding dsDNA length of each band a base-
pair ladder is often run alongside the sample in a separate well. Ladders are available 
commercially and will form pre-determined bands when analyzed by slab gel electrophoresis. 
Comparing the migration time of sample bands to those of the ladder allows for the estimation of 
the length of the dsDNA sequences present within the sample [62]. 
For slab gel electrophoresis large sample volumes can be applied to the gel for 
separation. As a result this separation can also be used for dsDNA cleanup. Using a ladder as a 
reference point, the bands of sample DNA corresponding to a desired length are carefully 
excised using a scalpel. The dsDNA can then be extracted from the gel using commercial gel 
extraction kits [63]. 
3.1.8.2.Capillary electrophoresis 
Capillary electrophoresis (CE) is an alternative method to PCR product analysis [64]. The 
CE set-up consists of a silica based narrow bore capillary which is filled with an electrolyte 
buffer, which varies depending on the desired conditions for separation. A small volume of the 
sample is injected into one end of the capillary by pressure. Both capillary ends are then placed 
into vials containing electrolyte solution as well as an electrode. An electric field is applied 
across the capillary resulting in the migration of sample components along the length of the 
capillary towards an electrode (Figure 3.1). An online detector interfaces with the capillary and 
is able to measure a signal (UV or fluorescence) from the sample components as they pass. The 
detector, in tum, interfaces with a computer, which records an electropherogram from the signal 
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Figure 3.1 A schematic of the capillary electrophoresis set-up adapted from [67]. 
intensity over time. Migration within the capillary lumen is due to electrophoretic and electro-
osmotic force-induced movement. Electrophoretic flow results from action of a uniform electric 
field along the capillary upon charged species. One buff er vial functions as the cathode and the 
other buffer vial functions as the anode. Based on their overall size to charge ratio, sample 
components will move within the capillary towards either the cathode or the anode at variable 
speeds. Small ions will move faster than large ions and negative ions will move towards the 
anode with the positive ions going towards the cathodes. This is the same mechanism, on which, 
nucleic acid separation within slab gel electrophoresis is based. However, due to a high surface 
area to volume ratio of the capillary used in CE a much larger current can be applied as 
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compared to slab gel electrophoresis. As a result, components can be separated directly within 
the capillary buffer and no gel is required [ 65]. 
Movement within the CE is also dependent on the electro-osmotic flow (EOF) within the 
capillary lumen. When a voltage is applied across the capillary buffer solution flows causing 
ionization of acidic silanol groups along the capillary wall. With a basic pH running buffer, 
silanol groups dissociate from the surface leaving behind a negatively charged surface, which 
attracts cations. During separation the cations will move towards the cathode and passively carry 
the water molecules in which they are dissolved. This creates an overall flow of solution within 
the capillary towards the cathode. In acidic conditions the reverse effect is seen with an overall 
EOF towards the anode [66]. 
The overall separation of species within a capillary will depend on the size to charge 
ratio. Typically the EOF is significantly stronger than the electrophoretic forces. As a result, all 
species in a sample are carried by the EOF in the same direction. However, the speed of each 
species will depend on their respective charge and size. The charge of a species will dictate the 
strength of the electrophoretic forces. The size and shape of a species will dictate the frictional 
forces experienced. Based on these distinctions numerous species within a single sample can be 
efficiently separated during CE [ 66]. 
PCR product analysis through CE provides several advantages. CE analysis requires a 
very small sample for accurate analysis as little as 7µL. Due to the presence of an on-line 
detector, separation and analysis occurs simultaneously resulting in faster analysis time as 
compared to slab gel electrophoresis. In addition CE has a lower limit of detection, which allows 
for the detection oflower DNA concentration than those seen with slab gel electrophoresis [65]. 
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3.2. Choice of experimental model 
An attempt was made to select aptamer against the 4Tl cell line. This model system is 
described in detail above (Chapter 2.3.1). The goal, of this portion, of the research project was to 
optimize the selection of aptamers for the 4T1 cell line by improving the specificity of the PCR 
amplification of collected sequences. 
3.3. Materials and methods 
3.3.1. Cell preparation 
4Tl cells were grown in RPMI 1640 medium (catalog# 30-2001, ATCC, Manassas, VA, 
USA) with 10% fetal bovine serum (FBS, catalog #SH30396.03, HyCyclone Laboratories, 
Logan, UT, USA) and 1 % 100 U/mL penicillin-streptomycin (penicillin-streptomycin solution 
catalog #P4333, Sigma- Aldrich, Oakville, ON, Canada) at 37 °C under humidified 5% C02• 
Cells were sub-cultured no more than 24 hours prior to selection to ensure that cells can be 
efficiently removed for selection. 
Plates were rinsed twice with Dulbecco's phosphate buffered saline (PBS, catalog 
#D8537, Sigma-Aldrich, Oakville, ON, Canada), and cells were detached using 2 ml of 0.05% 
Trypsin (Trypsin-EDTA Solution IX, catalog #59417C, Sigma-Aldrich, Oakville, ON, Canada) 
at 3 7 °C for no more than 1.5 minutes to minimize the degradation of cell surface proteins. Cells 
were then re-suspended 9 ml ofRPMI 1640 and 1 ml of FBS counted via hematocytometer, and 
spun down for 3 min at 150g and 4 °C. Medium was discarded, and cellular pellet was rinsed 
twice by re-suspending in 10 ml of PBS and gentle pipeting. The final pellet was suspended in 
PBS + 5mM MgCh. 
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3.3.2. DNA preparation 
All oligonucleotides were purchased from IDT (Coralville, IA, USA). All DNA used was 
6-carboxyfluorescein (FAM)-labeled at the 5' end. The masking DNA sequence was generated at 
random and modified to ensure no binding with the library primer regions ( 5 '-F AMI AA GGG 
TCC TGT GCT ATA ACT GTG GGT CTA GTG GTA TTT AG-3'). ssDNA library consisted of 
a 40-nt random region flanked by 20-nt-long primer regions (5'-FAM/AGC CTA ACG CAG 
AAC AAT GG-random region-CGA TGC CAG GTT AAA GCA CT-3'). 
Prior to incubation with target cells, masking DNA and library sequences were heated at 
95°C for 5 minutes and then snap cooled on ice to allow for the formation of stable three-
dimensional structures. 
3.3.3. Cell-SELEX against 4Tl cells 
Selection suspension was analyzed for the percentage of dead cells. Target cell 
suspension was incubated with 1 µL of lmg/ml propidium iodide (PI) for 5 minutes at 37°C. 
Following incubation cells were analyzed via flow cytometry for 30 000 events. Number of dead 
cells was determined by looking at the number of events with an RFU signal of 105 or higher 
with the PerCP-Cy5-5-A filter. Suspensions containing greater than 5% dead cells were 
discarded. 
Suspensions containing~ 5%, containing approximately 5 x 105 4Tl cells were incubated 
with masking DNA (determined based on a kappa of 5) at 3 7°C for 5 minutes while shaking at 
300rpm. Library was then added to the suspension and the cell-SELEX mixture was incubated 
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for 30 minutes at 37°C while shaking at 300 rpm. The suspension was spu~ down at 300g for 5 
minutes at 4°C and rinsed twice with PBS + 5mM MgCii. The final pellet was then re-suspended 
in 50µL of TE buffer pH 7.5 and heated to 95°C for 5 minutes to remove any unbound 
sequences. Suspension was then spun down at 13 000 g for 20 minutes at 4°C and supernatant 
was collected. 
3.3.4. PCR amplification 
Symmetric PCR master mix consisted of 300nM forward primer, 300nM reverse primer, 
1 x PCR Buffer (New England Biolabs Cat# M0273L, Mississauga, ON), 200 µM dNTPs and 1 
U/µL Taq DNA Polymerase (New England Biolabs, Cat# M0273L, Mississauga, ON). 
Asymmetric PCR mix consisted of 1 µM forward primer and 50nM reverse primer, 1 x PCR 
Buffer (New England Biolabs Cat# M0273L, Mississauga, ON), 200 µM dNTPs and 1 U/µL 
Taq DNA Polymerase (New England Biolabs, Cat# M0273L, Mississauga, ON). Standard PCR 
was performed by preheating at 94°C for 30 seconds followed by 10-15 cycles of template 
denaturation for 10 seconds at 94 °C, annealing for 10 seconds at 56°C and polymerization for 10 
seconds at 72°C. Touchdown PCR protocol consisted of preheating at 94°C for 30 seconds 
followed by 10-15 cycles of denaturation for 10 seconds at 94 °C, annealing for 10 seconds at a 
range of 66 - 56°C (with -1°C per cycle) and extension for 10 seconds at 72°C. 
53 
3.3.5. Analysis of PCR product 
PCR products were analyzed predominantly using capillary electrophoresis. To confirm 
size of produced sequences from genomic DNA amplification products were also analyzed using 
slab gel electrophoresis. 
3.3.5.1.Slab gel electrophoresis 
Agarose based gels were created using TAE (Tris base, acetic acid and EDTA) and a 2% 
agarose concentration. Products were visualized by adding I OµL of I Omg/ml ethidium bromide 
per 200 ml of running buffer (T AE). Product length was estimated by comparison to a 50bp 
DNA ladder (New England Biolabs, Cat# N3236S, Mississauga, ON). 
3.3.5.2.PCR product purification 
Following separation on a 2% agarose gel bands of interest (80bp) were excised using a 
scalpel and dsDNA was extracted using a commercial gel purification kit (Qiagen, Cat# 28704, 
Gaithersburg, MD). 
3.3.5.3.Capillary electrophoresis 
Capillary electrophoresis was performed in a capillary with an inner diameter of 75 µm 
and a total length of 50 cm. Running buffer consisted of 25mM Borax pH 9 .3. Samples were 
injected by 0.5 psi pressure for 5 seconds and separated at 30 kV for 15 minutes. 
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3.3.5.4.Quantification of Library Sequences 
The concentration of library sequences was estimated using the NanoDrop 3300 
Fluorospectrometer from Thermo Scientific. A standard curve was established using fluorescein 
labeled forward primers (Figure 3.2). Measurement of fluorescence was taken at 519 nm 
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Figure 3.2 Primer calibration curve established using a fluorospectrometer with 
measurements taken at a wavelength of 519 nm for a range of primer concentrations 
from 31.25nM to 2000nM. No fluorescence was detected for primer concentrations 
below lnM. 
emission wavelength for a range of primer concentrations from 31.25 nM to 2000 nM. 
Measurements were taken in triplicate and plotted to obtain a line of best fit (Figure 3.2). 
3.4 Results and discussion 
3.4.1. Decreasing Byproduct Formation 
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Aptamer selection was initiated by the incubation of a high library concentration (,...., 
14µM) with approximately 10x106 4Tl cells in suspension. This high initial library 
concentration is necessary to ensure that potential aptamers are present to and selection is 
successful [1]. Following incubation, cells were rinsed and bound sequences were collected by 
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Figure 3.3 An electropherogram of PCR products following the amplification of target 
bounds sequences, for 10 rounds of symmetric PCR, obtained from a single round of cell-
SELEX (blue) or two consecutive rounds of non-SELEX aptamer selection (green). 
heating and centrifugation. The concentration of collected sequences was estimated, using a 
fluorospectrometer and a previously established ssDNA calibration curve (Figure 3.2), to be 
approximately 200nM. All bound sequences were then amplified using symmetrical PCR (with 
equal concentration of forward and reverse primers) for 10 rounds. PCR products were analyzed 
via CE and are presented in Figure 3.3. 
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Due to the high template concentration over-amplification was evident after only 10 
rounds of PCR. The fact that the template was a heterogeneous mixture further increased the risk 
of byproduct production. Electropherogram of PCR products (Figure 3.3) showed a high 
byproduct yield. In fact the concentration of byproducts was comparable to the desired product 
concentration. The production of byproducts that are shorter than the target sequences is due to 
non-specific annealing between two template strands, which are then both amplified 
inaccurately. This results in the overall loss of template sequences from the PCR product pool. 
The loss of a high number of template sequences following a round of SELEX, especially so 
early in the selection process, can greatly hinder selection efficiency. 
To improve PCR amplification the template concentration needs to be decreased, ideally 
down to the pM range. The simplest way to do this is by simple dilution of collected sequences. 
However, because the concentration of the ssDNA collected after the first round is so high ( ~ 
200nM) the sample would need to be diluted over 200 times. Such a large dilution would result 
in large sample volumes ~ 1 Oml. Since the initial library contains as little as one copy of each 
unique sequence, the entire collected fraction would need to be amplified. PCR amplification of 
such large volumes would be tedious and extremely resource consuming. In addition, this would 
result in a final product volume of~ 100 ml of which, less than 1 % would be used for subsequent 
rounds of selection. This would introduce a high level of sampling error. If the fraction of pool 
one used for subsequent rounds contains a low concentration of high affinity sequences, as 
compared to the entire PCR product, than an increased number of rounds will be required. 
Previous work has demonstrated the successful selection of aptamers, against a purified 
target, using a non-SELEX approach [4]. In this modified aptamer selection procedure an 
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oligonucleotide library is incubated with the target of interest and bound and unbound sequences 
are collected. However, unlike traditional SELEX, non-SELEX aptamer selection does not 
perform an amplification step prior to the subsequent incubation (Figure 1.2) [ 4]. 
To decrease the number of target bound sequences, prior to PCR amplification, the non-
SELEX approach was combined with the traditional cell-SELEX protocol. Following the initial 
incubation of library, with target cells, the concentration of the collected ssDNA was estimated 
using a fluorospectrometer and determined to be in the high nM range. Therefore, the collected 
fraction was not amplified but instead used directly in a second round of selection with a fresh 
target cell suspension. Following the second round of non-SELEX selection the collected 
fraction ssDNA was not detectable using a fluorospectrometer, suggesting a concentration in the 
pM range. Following the second round of incubation the collected sequences were PCR 
amplified and the products were analyzed through CE (Figure 3.3). The decrease in template 
concentration resulted in a decrease in the formation of byproducts and improved yield of double 
stranded target sequences. The total PCR products including percentage of byproduct and desired 
product formed was estimated based on the total area beneath the appropriate peaks in Figure 
3.3. The percentage of byproduct formation decreased by 28% with the use of a non-SELEX 
approach, at the same time the relative percent yield of desired dsDNA product increased by 
28%. 
The use of two rounds of non-SELEX selection resulted in a sufficient decrease in the 
concentration of target bound sequences collected to allow for specific amplification via PCR 
resulting in significantly less byproduct formation. Such a non-SELEX approach allows for the 
decrease in non-specific sequences, while still maintaining specific sequences within the 
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collected fraction. Unlike the arbitrary dilution of ssDNA collected after incubation, the non-
SELEX approach allows for non-specific sequences to be diluted out, by consecutive incubations 
with target cells. At the same time, high affinity sequences bind to the target cell and therefore 
remain within the selection pool. While this approach has been used previously for the selection 
of aptamers against a purified product [ 4 ], to the best of our knowledge this is the first time it has 
been applied during cellular aptamer selection. 
3.4.2. Genomic DNA amplification 
3.4.2.1.Identification of a genomic DNA byproduct 
Following two rounds of non-SELEX selection, aptamer selection continued as per the 
typical cell-SELEX protocol described above (Chapter 1.2.1 ). Collected sequences were 
amplified using symmetric PCR followed by asymmetric PCR to increase the production of the 
sense target strand. All PCR products were analyzed via CE. Analysis of the third round PCR 
products revealed the presence of an additional peak following the expected dsDNA target peak 
(Figure 3.4). 
The amplification of genomic DNA would produce long dsDNA sequences significantly 
longer that the initial library length. Genomic DNA is released by the target cells during the 
elution of bound sequences by heating to 95°C. If a portion of the genomic DNA is able to bind 
to either primer sequences or a specific library sequence within the PCR suspension, the result 
would be amplification of the genomic DNA sequence. Genomic DNA is longer than the 80 nt 
library and therefore its amplification will result in ·dsDNA byproduct that will appear after the 
library amplicons on the electropherogram (Figure 3.4). To confirm that the contamination peak 
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Figure 3.4 An electropharogram of asymmetric PCR products of three consecutive rounds 
of cell-SELEX showing the desired dsDNA product eluting shortly after 13 minutes and a 
genomic byproduct eluting at 14 minutes. Round 1, 2 and 3 are shown as red, blue and green 
traces respectively. 
with dsDNA, longer than 80 nt in length agarose slab gel electrophoresis was performed. DNA 
bands were intercalated with ethidium bromide and visualized under UV light (Figure 3.5). Slab 
gel electrophoresis confirmed that the peak seen on CE was in fact a dsDN A sequence greater 
than 400 bp in length. 
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During the subsequent three rounds of cell-SELEX the peak gradually became larger than 
the desired dsDNA product peak. Eventually the genomic DNA was the predominant dsDNA 
product following asymmetric PCR. This suggested that the PCR amplification of the target pool 
resulted in the additional amplification of genomic DNA. Since the amount of genomic DNA 
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Figure 3.5 Agarose gel electrophoresis of the PCR products produced from the amplification 
of the third round of cell-SELEX (corresponding to the green trace on Figure 3.3) as well as 
the asymmetric amplification of a naive library. The dsDNA product of each sample is 
outlined with a blue box showing a 80bp long product formed from library amplification and a 
broad band over 300bp long formed from cell-SELEX round 3 pool of sequences 
61 
PCR product increased as selection progressed, this suggests that the genomic DNA was not only 
amplified at each round but was able to bind to target cells with a sufficiently strong affinity to 
be collected from round to round (Figure 3.4). 
3.4.2.2.Slab gel purification 
In order to eliminate the contamination of the selected library sequences, with amplified 
genomic DNA, an attempt was made to purify PCR products following slab gel electrophoresis. 
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Figure 3.6 Electropharogram of PCR products of sequences collected following one round of 
cell-SELEX. Symmetric PCR products pre-clean-up (red) and following gel purification (blue) 
show the presence of the expected dsDNA product peak eluting shortly after 13 minutes. Gel 
purified products were amplified by asymmetric PCR (green) showing no genomic DNA 
amplification byproducts. 
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Following symmetric PCR products were separate through slab gel electrophoresis and the band 
of interest was excised. The dsDNA was extracted using a commercially acquired kit and was 
further amplified using asymmetric PCR. All products were analyzed by CE. 
The purification process resulted in a significant decrease in the concentration of the 
target sequences (Figure 3.6). On a positive note, the purification step eliminated any visible 
genomic DNA amplification of the gel purified symmetric PCR product (Figure 3.6). 
Overall the gel purification of PCR products is significantly time consuming and added 
an extra 3 hours to each round of aptamer selection. In addition the decreased concentration of 
the amplified library sequences following purification implies a loss of sequences. Such a loss of 
sequences could greatly impede the aptamer selection process (as mentioned earlier) especially 
in the early rounds of selection when high affinity sequences may not necessarily be dominant 
within the selection pool. 
3.4.2.3. Decreasing Genomic Amplification Through Touchdown PCR 
Instead of attempting to purify PCR products, it would be ideal to decrease or eliminate 
genomic DNA amplification in the first place. Genomic DNA amplification occurs because of 
ssDNA sequences annealing to the genomic DNA. Since the genomic DNA is clearly visualized 
by fluorescence during CE, it is safe to assume that genomic amplification is likely due to the 
forward primer annealing to the genomic DNA, since the forward primer is the only one labeled 
with a fluororphore. This is further confirmed by the fact that genomic DNA amplification 
becomes noticeable following asymmetric PCR, in which the forward primer concentration is 20 
times higher than that of the reverse primer. Thus, to decrease the amplification we need to be 
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able to increase the annealing stringency of primers to the primer regions of target ssDNA 
sequences during the annealing step of a PCR cycle. 
The specificity of any PCR reaction is directly a reflection of the level of stringency 
involved in the primer sequence annealing to template strands [57]. When annealing stringency 
is high primer sequences anneal by perfect base pairing to their target. Consequently, as 
stringency decreases primers can bind to other sequences that are not perfect base pair matches. 
Overall, the primer binding stringency is determined by the annealing temperature, which can be 
determined mathematically or experimentally for a primer sequence and a specific PCR reaction 
[57]. Since the ideal annealing temperature is dependent on many factors, optimizing it is very 
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Figure 3. 7 Electropharogram of touchdown asymmetric PCR product of round 7 (blue) and 
round 1 (green) using traditional PCR amplification of cell-SELEX against the 4Tl cell line. 
Double stranded desired product is shown eluting after 13 minutes and genomic DNA at 
approximately 14 minutes in the green trace only. 
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cumbersome and time consuming. Instead of optimizing the annealing temperature touchdown 
PCR can be used to increase stringency without the need of optimizing a single annealing 
temperature [59]. 
Touchdown PCR was set-up by using a range of annealing temperatures starting at 10°C 
above the primer Tm· The touchdown protocol consisted of a gradual decrease in annealing 
temperature by 1°C per round of amplification. The touchdown method was applied to both the 
symmetric and asymmetric amplification of DNA collected at the end of a round of cell-SELEX. 
In total nine rounds of selection were performed and no genomic DNA byproduct was observed 
during CE analysis of asymmetric PCR products (Figure 3. 7). 
Overall this suggests that touchdown PCR is an effective way of decreasing/eliminating 
the amplification of genomic DNA within the cell-SELEX fraction. It is a simple protocol to 
incorporate into pre-existing PCR methodology. In addition, touchdown PCR does not require 
any additional equipment, additional ~teps or optimization [ 61]. 
3.5. Conclusions and future directions 
The above experiments offer two simple, yet efficient ways of improving the traditional 
cell-SELEX protocol. Introducing a non-SELEX approach, at the start of aptamer selection 
against a cell line, lead to a significant decrease in the formation of small byproducts during PCR 
amplification. While non-SELEX aptamer selection has been previously used to identify 
aptamers against a purified target [4], it had not previously been applied in combination with the 
traditional cell-SELEX protocol. 
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Genomic DNA amplification was virtually eliminated by modifying the existing 
amplification protocols with a touchdown annealing temperature. This adjustment in the PCR 
protocol resulted in elimination of genomic DNA amplification product after as many as nine 
rounds of aptamer selection. The removal of genomic DNA contamination resulted in a modest 
improvement in the binding affinity as selection progressed. Both techniques suggested above 
were able to not only improve the cell-SELEX protocol but were also able to do so in a simple 
manner without relying on excessive reagents, equipment, time or optimization. The above 
experiments have been able to obtain some improvement in the binding affinity following the 
seventh round of selection against the 4Tl cell line. Several more rounds of cell-SELEX, 
modified with the above specifications, need to be completed before potential sequences can be 
cloned and screened for aptamer applications. 
To further improve the binding affinity of the selection pool, better separation techniques 
need to be introduced to separate out aptamers from the non-specifically binding sequences. 
Improved separation techniques of bound and unbound sequences would further improve the 
efficiency of the cell-SELEX procedure. If such separation techniques are combined with the 
above techniques including the masking DNA model to decrease non-specific binding, aptamer 
selection against target cell line should show significant improvement. 
Obtaining aptamers against the 4Tl cell line would be a valuable research tool for the in 
vivo study of breast cancer metastasis with in a mouse model system. The 4Tl cell line is 
commonly used in the study of tumor progression and having aptamers against such a commonly 
used cell line would allow for improvements in research. Specifically, aptamers could be used 
for targeting imaging probes, allowing for the observation of metastatic tumor progression. At 
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the same time, conjugation of cancer drugs to the aptamer along with an imaging probe could be 
used to gain better insight into treatment effiCiency of specific therapies. On a broader scope, the 
cell-SELEX optimizations presented in my work can be used to improve aptamer selection 
against any cell line. Improving the aptamer selection procedure will lead to selection of a 
greater number and variety of aptamer sequences, which can subsequently be applied within the 
research and/or clinical settings. 
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